Bivalirudin Injection, Powder, Lyophilized, For Suspension
Product Images NDC 70436-025

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 70436-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Image 01)

FDA Label Image

Vial-label-v1.2 (Image 02)

Vial-label-v1.2 (Image 02)
This is a medication label for the drug Bivalirudin used for intravenous use only. It is provided as an injection and comes in vials of 20g. The impact on storage shows that it should be stored between 20 and 25 degrees Celsius. Additionally, it mentions that the unused portion must be discarded. The rest of the text is unclear or unreadable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.